Treatment of Relapsed Myeloma with Second Stem Cell Transplant Appears Safe (01-4-2012)

For multiple myeloma patients who relapse after initial treatment with an autologous stem cell transplant, salvage treatment with a second autologous stem cell transplant appears to be safe and to produce response rates that are similar to other treatment... Continue Reading

Coffee May Cut Uterine Cancer Risk (11-30-2011)

Women who consume four or more cups a coffee per day may have a lower risk of endometrial cancer (cancer of the lining of the uterus) than women who drink very little or no coffee. These results were published in Cancer Epidemiology, Biomarkers, &... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (11-29-2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (11-29-2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (11-29-2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (11-29-2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

Rindopepimut Continues to Show Promise Against Glioblastoma (11-23-2011)

According to longer-term follow-up of a Phase II clinical trial, the investigational vaccine rindopepimut (CDX-110) may improve overall survival with glioblastoma mutiforme (GBM). These results were presented at the 2011 annual meeting of the Society... Continue Reading

Rindopepimut Continues to Show Promise Against Glioblastoma (11-23-2011)

According to longer-term follow-up of a Phase II clinical trial, the investigational vaccine rindopepimut (CDX-110) may improve overall survival with glioblastoma mutiforme (GBM). These results were presented at the 2011 annual meeting of the Society... Continue Reading

Rindopepimut Continues to Show Promise Against Glioblastoma (11-23-2011)

According to longer-term follow-up of a Phase II clinical trial, the investigational vaccine rindopepimut (CDX-110) may improve overall survival with glioblastoma mutiforme (GBM). These results were presented at the 2011 annual meeting of the Society... Continue Reading

Rindopepimut Continues to Show Promise Against Glioblastoma (11-23-2011)

According to longer-term follow-up of a Phase II clinical trial, the investigational vaccine rindopepimut (CDX-110) may improve overall survival with glioblastoma mutiforme (GBM). These results were presented at the 2011 annual meeting of the Society... Continue Reading

FDA Revokes Avastin’s Approval for Breast Cancer (11-22-2011)

The US Food and Drug Administration (FDA) is revoking the approval of Avastin® (bevacizumab) for the treatment breast cancer. The FDA concluded that Avastin has not been shown to be safe and effective for this purpose. This decision does not affect the... Continue Reading

FDA Revokes Avastin’s Approval for Breast Cancer (11-22-2011)

The US Food and Drug Administration (FDA) is revoking the approval of Avastin® (bevacizumab) for the treatment breast cancer. The FDA concluded that Avastin has not been shown to be safe and effective for this purpose. This decision does not affect the... Continue Reading